Burlington, MA30+ days ago
Founded in 2003 by a team of Taiwanese-American executives and renowned scientists from U.S. biotechnology and pharmaceutical companies, today we are listed on the Taiwan Stock Exchange (TWSE: 6446) and are expanding our global presence with operations in the U.S., Japan, Singapore, South Korea, and China, along with a world-class biologics production facility in Taichung. Serving as a bridge between external vendors and internal Patient Access leadership, the role uses performance data and operational insight to drive continuous improvement, mitigate risk, and optimize coordination across internal teams, HUB services, Specialty Pharmacies, and copay vendors.